Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says.Cheaper versions of ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

People can get prescriptions through telehealth, and the cost is lower than traditional prescriptions not covered by insurance. Weight loss drugs that use tirzepatide as the active ingredient cost ...

Costs will vary depending on insurance plans ... Some online retailers claim to sell “generic” Mounjaro or tirzepatide, which is actually a compounded drug. Drug compounding is the process ...

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.

Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:NVO) ...

Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025. Patients could face higher costs and tougher access, and telehealth is racing to adapt. The FDA has ...